BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19493992)

  • 1. Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
    StGelais C; Foster TL; Verow M; Atkins E; Fishwick CW; Rowlands D; Harris M; Griffin S
    J Virol; 2009 Aug; 83(16):7970-81. PubMed ID: 19493992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
    Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
    J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
    Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    Walter S; Bollenbach A; Doerrbecker J; Pfaender S; Brown RJP; Vieyres G; Scott C; Foster R; Kumar A; Zitzmann N; Griffin S; Penin F; Pietschmann T; Steinmann E
    J Virol; 2016 May; 90(10):5075-5089. PubMed ID: 26962224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system.
    StGelais C; Tuthill TJ; Clarke DS; Rowlands DJ; Harris M; Griffin S
    Antiviral Res; 2007 Oct; 76(1):48-58. PubMed ID: 17574688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    Castelain S; Bonte D; Penin F; François C; Capron D; Dedeurwaerder S; Zawadzki P; Morel V; Wychowski C; Duverlie G
    J Med Virol; 2007 Feb; 79(2):144-54. PubMed ID: 17177298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of viral escape mutations within HCV p7 during treatment with amantadine in patients with chronic hepatitis C.
    Vermehren A; Welsch C; Elsler U; Vermehren J; Herrmann E; Sarrazin C; von Wagner M; Susser S; Hofmann WP; Kronenberger B; Zeuzem S; Mihm U
    Antivir Ther; 2013; 18(6):803-11. PubMed ID: 23824381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
    Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
    Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
    Khaliq S; Jahan S; Hassan S
    Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
    Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
    PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study.
    Behmard E; Abdolmaleki P; Taghdir M
    Biophys Chem; 2018 Feb; 233():47-54. PubMed ID: 29169687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
    Ying B; Pang S; Yang J; Zhong Y; Wang J
    Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
    Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
    J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
    Griffin S
    Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance.
    Cook GA; Dawson LA; Tian Y; Opella SJ
    Biochemistry; 2013 Aug; 52(31):5295-303. PubMed ID: 23841474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and functional heterogeneity of the hepatitis C virus p7 ion channel during natural chronic infection.
    Li H; Atkins E; Bruckner J; McArdle S; Qiu WC; Thomassen LV; Scott J; Shuhart MC; Livingston S; Townshend-Bulson L; McMahon BJ; Harris M; Griffin S; Gretch DR
    Virology; 2012 Feb; 423(1):30-7. PubMed ID: 22172518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of pore-lining residues in the hepatitis C virus p7 protein.
    Chew CF; Vijayan R; Chang J; Zitzmann N; Biggin PC
    Biophys J; 2009 Jan; 96(2):L10-2. PubMed ID: 19167280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.